Infection of primary human monocytes by Epstein-Barr virus

Journal of Virology

Volumn 74, Issue 6, 2000, Pages 2612-2619

  Savard, Martin ^a   Bélanger, Carole ^a   Tardif, Mélanie ^a   Gourde, Pierrette ^a   Flamand, Louis ^a   Gosselin, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

CELL NUCLEUS; CELLS, CULTURED; DNA, VIRAL; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MONOCYTES; PHAGOCYTOSIS; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRION;

EID: 0343775822     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.6.2612-2619.2000     Document Type: Article

References (54)

1. Adams, D. O., and T. A. Hamilton. 1992. Macrophages as destructive cells in host defense, p. 637-662. In J. I. Gallin, I. M. Goldstein, and R. Snyderman (ed.), Inflammation: basic principles in clinical correlates, 2nd ed. Raven Press, New York, N.Y.
2. Andoh, A., Y. Fujiyama, K. Kitoh, K. Hodohara, T. Bamba, and S. Hosoda. 1991. Flow cytometric assay for phagocytosis of human monocytes mediated via Fcγ-receptors and complement receptor CR1 (CD35). Cytometry 12: 677-686.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Séguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Baldwin, G. C., J. Fleischmann, Y. Chung, Y. Koyanagi, I. S. Chen, and D. W. Golde. 1990. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA 87:3933-3937.
5. Beaulieu, A. D., R. Paquin, and J. Gosselin. 1995. Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 86:2789-2798.
6. Bender, B. S., B. L. Davidson, R. Kline, C. Brown, and T. C. Quinn. 1988. Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev. Infect. Dis. 10:1142-1154.
7. Bender, B. S., M. M. Frank, T. J. Lawley, W. J. Smith, C. M. Brickman, and T. C. Quinn. 1985. Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J. Infect. Dis. 152: 409-412.
8. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Sturz. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:7963-7968.
9. Buschmann, H., and M. Winter. 1989. Assessment of phagocytic activity of granulocytes using laser flow cytometry. J. Immunol. Methods 124:231-234.
10. Cohen, J. I., and K. Lekstrom. 1999. Epstein-Barr Virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol. 73:7627-7632.
11. Delsol, G., F. Meggetto, P. Brousset, E. Cohen-Knafo, T. Al Saati, and P. Rochaix. 1993. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am. J. Pathol. 142:1729-1739.
12. Denholm, E. M., and F. M. Wolber. 1991. A simple method for the purification of human peripheral blood monocytes. J. Immunol. Methods 144: 247-251.
13. Ercolani, L., B. Florence, M. Denaro, and M. Alexander. 1988. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263:15335-15341.
14. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
15. Goldsmith, K., L. Bendell, and L. Frappier. 1993. Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 67:3418-3426.
16. Gosselin, J., and P. Borgeat. 1997. Epstein-Barr virus modulates 5-lipoxy-genase product synthesis in human peripheral blood mononuclear cells. Blood 89:2122-2130.
17. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, and J. Menezes. 1992. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin-6 and tumor necrosis factor alpha. J. Clin. Investig. 89:1849-1856.
18. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, I. Stephanescu, D. V. Ablashi, R. C. Gallo, and J. Menezes. 1992. Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infection and co-infection on cytokine synthesis. J. Immunol. 149:181-187.
19. Gosselin, J., J. Menezes, M. D'Addario, J. Hiscott, L. Flamand, G. Lamoureux, and D. Oth. 1991. Inhibition of tumor necrosis factor-α transcription by Epstein-Barr virus. Eur. J. Immunol. 21:203-208.
20. Greenberg, S. 1995. Signal transduction of phagocytosis. Trends Cell Biol. 5:93-99.
21. + T lymphocytes. Anticancer Res. 18:3171-3180.
22. Heller, A., T. Koch, J. Schmeck, and K. van Ackern. 1998. Lipid mediators in inflammatory disorders. Drugs 55:487-496.
23. Herbst, H., F. Dallenbach, M. Hummel, G. Niedobitek, S. Pileri, K. Müller-Lantzsch, and H. Stein. 1991. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 88:4766-4770.
24. Kaneko, T., J. Fukuda, T. Yoshihara, H. Zheng, S. Mori, H. Mizoguchi, and K. Oshimi. 1995. Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br. J. Haematol. 91:355-361.
25. Keles, I., Z. Woldehiwet, and R. D. Murray. 1998. The effects of bovine respiratory syncytial virus on the phagocytic and antigen-presenting capacity of peripheral blood monocytes and monocytic cell lines derived from lambs and calves. J. Comp. Pathol. 118:347-357.
26. Kelleher, C. A., R. Kaufmann Paterson, D. H. Dreyfus, J. E. Streib, J. W. Hu, K. Takase, J. F. Jones, and E. W. Gelfand. 1995. Epstein-Barr virus replicative-gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208:685-695.
27. Kent, S. J., G. Stent, S. Sonza, S. D. Hunter, and S. M. Crowe. 1994. HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression. Clin. Exp. Immunol. 95:450-454.
28. Kieff, E. 1996. Epstein-Barr virus: pathogenesis and pathology, p. 2343-2394.
29. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
30. Koide, J., K. Takada, M. Sugiura, H. Sekine, T. Ito, K. Saito, S. Mori, T. Takeuchi, S. Uchida, and T. Abe. 1997. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J. Virol. 71:2478-2481.
31. Kondo, K., T. Kondo, T. Okuno, M. Takahashi, and K. Yamanishi, 1991. Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol. 72:1401-1408.
32. Langermans, J. A., W. L. Hazenbos, and R. van Furth. 1994. Antimicrobial functions of mononuclear phagocytes. J. Immunol. Methods 174:185-194.
33. Larochelle, B., L. Flamand, P. Gourde, D. Beauchamp, and J. Gosselin. 1998. Epstein-Barr virus infects and induces apoptosis in human neutrophils. Blood 92:291-299.
34. Larsson, S., C. Soderberg-Naucler, and E. Moller. 1998. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission. Transplantation 65:411-415.
35. Lavin, D. P., A. G. Fredrickson, and F. Srienc. 1990. Flow cytometric measurement of rates of particle uptake from dilute suspensions by a ciliated protozoan. Cytometry 11:875-882.
36. Lupton, S., and A. J. Levine. 1985. Mapping of genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5:2533-2542.
37. Maciejewski, J. P., E. D. Burening, R. E. Donahue, S. E. Sellers, C. Carter, N. S. Young, and S. St. Jeor. 1993. Infection of mononucleated phagocytes with human cytomegalovirus. Virology 195:326-336.
38. Mendoza, E. C., T. G. Paglieroni, and J. B. Zeldis. 1996. Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus. J. Infect. Dis. 174:842-844.
39. Menezes, J., M. Jondal, W. Leibold, and G. Dorval. 1976. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect. Immun. 13:303-310.
40. Menezes, J., W. Leibold, and G. Klein. 1975. Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction. Exp. Cell Res. 92:478-484.
41. Morgan, A. J., and A. Douglas Wilson. 1997. Epstein-Barr virus gp350 vaccines. Epstein-Barr Virus Rep. 4:33-39.
42. Polyak, S., H. Chen, D. Hirsch, I. George, R. Hershberg, and K. Sperber. 1997. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159:2177-2188.
43. 2 regulation of the immune response. Adv. Prostaglandin Thromboxane Leukot. Res. 22:101-111.
44. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Shimakage, M., M. Kamura, S. Yanoma, M. Ibe, S. Yokota, G. Tsujino, T. Kozuka, T. Dezawa, S. Tamura, A. Obshima, M. Yutsudo, and A. Hakura. 1999. Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch. Virol. 144:157-166.
46. Skare, J., J. Farley, J. L. Strominger, K. O. Fresen, M. S. Cho, and H. zur Hausen. 1985. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J. Virol. 55:286-297.
47. Sprenger, H., R. G. Meyer, A. Kaufmann, D. Bussfeld, E. Rischkowsky, and D. Gemsa. 1996. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J. Exp. Med. 184:1191-1196.
48. Steinkamp, J. A., J. S. Wilson, G. C. Saunders, and C. C. Stewart. 1982. Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 215:64-66.
49. Strockbine, L. D., J. I. Cohen, T. Farrah, S. D. Lyman, F. Wagener, R. F. DuBose, R. J. Armitage, and M. K. Spriggs. 1998. The Epstein-Barr Virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
50. Sudgen, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication in latent infection. J. Virol. 63:2644-2649.
51. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
52. Thomas, C. A., O. K. Weinberger, B. L. Ziegler, S. Greenberg, I. Schieren, S. C. Silverstein, and J. El Khoury. 1997. Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism. Blood 90:3760-3765.
53. Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84:3452-3456.
54. Yoo, J., H. Chen, T. Kraus, D. Hirsch, S. Polyak, I. George, and K. Sperber. 1996. Altered cytokine production and accessory cell function after HIV-1 infection. J. Immunol. 157:1313-1320.